Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy

ClinicalTrials.gov ID: NCT01499095

Public ClinicalTrials.gov record NCT01499095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 3:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

6-Month, Multicenter, Randomized, Open-label, Parallel-group Study Comparing the Efficacy and Safety of a New Formulation of Insulin Glargine and Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Patients With Type 2 Diabetes Mellitus With a 6-month Safety Extension Period

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objective: * To compare the efficacy of insulin glargine new formulation and Lantus in terms of change in Glycated Hemoglobin A1c (HbA1c) from baseline to endpoint (scheduled Month 6) in adult participants with type 2 diabetes mellitus Secondary Objective: * To compare the efficacy of insulin glargine new formulation and Lantus in terms of occurrence of nocturnal hypoglycemia

Study identification

NCT ID
NCT01499095
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
811 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2011 (Type not available)
Primary completion
Apr 2013 (Actual)
Completion
Nov 2013 (Actual)
Last update posted
Mar 23, 2022

2011 – 2013

United States locations

U.S. sites
110
U.S. states
33
U.S. cities
93
Facility City State ZIP Site status
Investigational Site Number 840517 Birmingham Alabama 35213 —
Investigational Site Number 840149 Chandler Arizona 85224 —
Investigational Site Number 840093 Glendale Arizona 85306 —
Investigational Site Number 840069 Phoenix Arizona 85028 —
Investigational Site Number 840110 Sun City Arizona 85351 —
Investigational Site Number 840068 Tempe Arizona 85282 —
Investigational Site Number 840015 Hot Springs Arkansas 71913 —
Investigational Site Number 840014 Little Rock Arkansas 72205 —
Investigational Site Number 840114 Little Rock Arkansas 72205 —
Investigational Site Number 840018 Mountain Home Arkansas 72653 —
Investigational Site Number 840027 Searcy Arkansas 72143 —
Investigational Site Number 840074 Anaheim California 92801 —
Investigational Site Number 840509 Bell Gardens California 90201 —
Investigational Site Number 840060 Greenbrae California 94904 —
Investigational Site Number 840057 La Jolla California 92037 —
Investigational Site Number 840003 La Mesa California 91942 —
Investigational Site Number 840026 Los Angeles California 90073 —
Investigational Site Number 840090 Mission Hills California 91345 —
Investigational Site Number 840099 Palm Springs California 92262 —
Investigational Site Number 840004 San Diego California 92161 —
Investigational Site Number 840124 Santa Barbara California 93110 —
Investigational Site Number 840012 Tustin California 92780 —
Investigational Site Number 840104 Colorado Springs Colorado 80906 —
Investigational Site Number 840128 Colorado Springs Colorado 80909 —
Investigational Site Number 840098 Denver Colorado 80206 —
Investigational Site Number 840518 Brandon Florida 33511 —
Investigational Site Number 840049 Daytona Beach Florida 32117 —
Investigational Site Number 840008 Jacksonville Florida 32258 —
Investigational Site Number 840520 Miami Florida 33015 —
Investigational Site Number 840025 New Port Richey Florida 34652 —
Investigational Site Number 840011 Ocoee Florida 34761 —
Investigational Site Number 840141 Palm Harbor Florida 34684 —
Investigational Site Number 840513 Pembroke Pines Florida 33029 —
Investigational Site Number 840528 Columbus Georgia 31901 —
Investigational Site Number 840050 Idaho Falls Idaho 83404 —
Investigational Site Number 840107 Nampa Idaho 83686 —
Investigational Site Number 840199 Chicago Illinois 60612 —
Investigational Site Number 840021 McHenry Illinois 60050 —
Investigational Site Number 840020 Springfield Illinois 62704 —
Investigational Site Number 840045 Avon Indiana 46123 —
Investigational Site Number 840077 Avon Indiana 46123 —
Investigational Site Number 840088 Avon Indiana 46123 —
Investigational Site Number 840089 Avon Indiana 46123 —
Investigational Site Number 840091 Avon Indiana 46123 —
Investigational Site Number 840130 Evansville Indiana 47714 —
Investigational Site Number 840142 Lafayette Indiana 47904 —
Investigational Site Number 840041 Paducah Kentucky 42003 —
Investigational Site Number 840034 Baltimore Maryland 21237 —
Investigational Site Number 840150 Baltimore Maryland 21237 —
Investigational Site Number 840031 Rockville Maryland 20852 —
Investigational Site Number 840063 Ann Arbor Michigan 48106 —
Investigational Site Number 840064 Dearborn Michigan 48124 —
Investigational Site Number 840094 Flint Michigan 48504 —
Investigational Site Number 840023 Southfield Michigan 48034 —
Investigational Site Number 840066 Eagan Minnesota 55122 —
Investigational Site Number 840081 Minneapolis Minnesota 55416 —
Investigational Site Number 840158 Biloxi Mississippi 39531 —
Investigational Site Number 840526 Chesterfield Missouri 63017 —
Investigational Site Number 840502 Butte Montana 59701 —
Investigational Site Number 840084 Fremont Nebraska 68025 —
Investigational Site Number 840085 Omaha Nebraska 68130 —
Investigational Site Number 840162 Las Vegas Nevada 89102 —
Investigational Site Number 840527 Las Vegas Nevada 89117 —
Investigational Site Number 840056 Las Vegas Nevada 89148 —
Investigational Site Number 840135 Summit New Jersey 07901 —
Investigational Site Number 840145 Toms River New Jersey 08721 —
Investigational Site Number 840087 Toms River New Jersey 08753 —
Investigational Site Number 840140 Calabash North Carolina 28467 —
Investigational Site Number 840139 Hickory North Carolina 28601 —
Investigational Site Number 840153 Hickory North Carolina 28601 —
Investigational Site Number 840047 Wilmington North Carolina 28401 —
Investigational Site Number 840024 Winston-Salem North Carolina 27103 —
Investigational Site Number 840065 Fargo North Dakota 58103 —
Investigational Site Number 840007 Cincinnati Ohio 45236 —
Investigational Site Number 840097 Columbus Ohio 43213 —
Investigational Site Number 840113 Dayton Ohio 45439 —
Investigational Site Number 840108 Maumee Ohio 43537 —
Investigational Site Number 840504 Eugene Oregon — —
Investigational Site Number 840080 Medford Oregon 97504 —
Investigational Site Number 840148 Tipton Pennsylvania 16684 —
Investigational Site Number 840005 Uniontown Pennsylvania 15401 —
Investigational Site Number 840076 Greer South Carolina 29651 —
Investigational Site Number 840503 Simpsonville South Carolina 29681 —
Investigational Site Number 840048 Rapid City South Dakota 57701 —
Investigational Site Number 840028 Bristol Tennessee 37620 —
Investigational Site Number 840038 Chattanooga Tennessee 37404 —
Investigational Site Number 840042 Knoxville Tennessee 37912 —
Investigational Site Number 840160 Memphis Tennessee 38119 —
Investigational Site Number 840033 Memphis Tennessee 38125 —
Investigational Site Number 840022 Austin Texas 78731 —
Investigational Site Number 840078 Austin Texas 78758 —
Investigational Site Number 840519 Corpus Christi Texas 78404 —
Investigational Site Number 840001 Dallas Texas 75230 —
Investigational Site Number 840159 Dallas Texas 75231 —
Investigational Site Number 840115 Dallas Texas 75246 —
Investigational Site Number 840079 Houston Texas 77030 —
Investigational Site Number 840514 Houston Texas 77074 —
Investigational Site Number 840525 San Antonio Texas 78229 —
Investigational Site Number 840161 San Antonio Texas 78258 —
Investigational Site Number 840009 Draper Utah 84020 —
Investigational Site Number 840037 Orem Utah 84058 —
Investigational Site Number 840510 Salt Lake City Utah 84107 —
Investigational Site Number 840032 Chesapeake Virginia 23321 —
Investigational Site Number 840040 Norfolk Virginia 23510 —
Investigational Site Number 840095 Richmond Virginia 23235 —
Investigational Site Number 840072 Williamsburg Virginia 23185 —
Investigational Site Number 840134 Winchester Virginia 22601 —
Investigational Site Number 840523 Olympia Washington 98502 —
Investigational Site Number 840122 Walla Walla Washington 99362 —
Investigational Site Number 840019 Milwaukee Wisconsin 53209-0996 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 103 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01499095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2022 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01499095 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →